Guide for recalling medical devices (GUI-0054): Overview

This guidance document will come into force on December 14, 2024. Read the current Guide to Recall of Medical Devices (GUI-0054)

Date adopted: July 26, 2024
Effective date: December 14, 2024
Replaces: Guide to Recall of Medical Devices (GUI-0054), version 3, November 3. 2016

Disclaimer: This guide is an administrative document and does not constitute legislation. If there's any inconsistency or conflict between the legislation and this guidance document, the legislation takes precedence. This guide is intended to help regulated parties comply with the legislation and the applicable administrative policies.

On this page

Purpose

Recalling a product generally means removing it from sale or correcting a device. In Canada, actions such as notifying users of a potential problem or supplying different labelling for a medical device are also considered recalls.

This guide is for manufacturers, importers and distributors who work with medical devices.

It will help you:

Scope

This guide applies to the following sections of the Medical Devices Regulations (regulations) that are concerned with recalls:

To determine which sections of the regulations apply to you when you're involved in a recall, refer to the following table. The requirements will vary depending on whether you're a manufacturer, importer or distributor.

Table 1: Sections of the regulations that apply, by activity
Requirement Section Manufacturer Importer Distributor
Part I – General
Distribution records S.52 Yes Yes Yes
S.53 Yes Yes Yes
S.54 Yes No No
S.55 Yes Yes Yes
S.56 Yes Yes Yes
Recall procedure S.58b Yes Yes Yes
Recall reporting S.63.1 Yes Yes No
S.63.2 Yes Yes No
S.64 Yes Yes No
S.65 Yes Yes No
Recall records S.65.3 Yes Yes No
S.65.4(1) to (2) No No Yes
S. 65.6(1) Yes No No
S.65.6(2) No Yes Yes
Part 3 – Medical devices for investigational testing involving human subjects
Distribution record S.88(a) Yes Yes Yes
Recall S.88(d) Yes Yes No

Responsibilities

Recall actions are a collaborative process between all parties involved in the distribution chain, such as:

An effective collaboration between a manufacturer and its importers and distributors depends, in part, on the extent to which each establishment:

Manufacturers sometimes have special agreements with their importers or distributors to facilitate recalls. These agreements could include having access to distributors' distribution records or having a contract with distributors that guarantees their cooperation during a recall.

Chart 1 shows the responsibilities of and relationship between all regulated parties (manufacturers, importers and distributors) involved in the distribution chain. For more information on the recall process, refer to the section on recall process.

Chart 1: Responsibilities and relationships of regulated parties

This chart list the responsibilities of each regulated party in the recall process.

Long description

This flow chart is divided into 4 columns or streams labelled "distributors", "recalling company", "importers" and "Health Canada".

The 3 stages that apply to distributors (first column) are to notify and correct, follow up, and review and close.

In the "recalling company" stream (second column), the recalling company is directed through all 5 stages and the steps that must be taken at each stage. If there's a defective device or label, the company is directed to determine the need for recall (stage 1), which prompts the need to submit a 24-hour recall notification for reportable recalls (Health Canada stream). The recalling company is directed to develop the recall strategy (stage 2), then to notify and correct (stage 3). A note at this stage indicates the following: "In some cases, the importer and distributor may provide their distribution list to the recalling company who will conduct the notification on their behalf. Companies using this approach are still required to have a documented recall process and comply with any applicable reporting requirements". The recalling company is directed to submit an initial recall report (section 64) (applicable for reportable recalls) to Health Canada. The recalling company is then directed to follow up (stage 4) and review and close (stage 5).

Column 3 sets out the responsibilities of the importer, who is directed to submit a 24-hour recall notification if they initiate their own recall independent from the manufacturer. At stage 3, to notify and correct, the importer is directed to submit an initial recall report to Health Canada. The next 2 stages are to follow up, review and close, which involves submitting a final recall report to Health Canada (section 65, applicable for reportable recalls).

Introduction

This section gives an overview of information found in this guide. Use it to quickly locate the appropriate information and remind yourself of your key regulatory requirements.

Key requirements

Under the regulations, if you manufacture, import or distribute medical devices, you must:

Manufacturers and importers must also report recalls to Health Canada.

Note: Depending on whether you are a manufacturer, importer or distributor, compliance requirements will differ.

Establishments with a medical device establishment licence (MDEL) must also keep written procedures, with step-by-step instructions, on how to maintain distribution and recall records, and conduct recalls.

Learn more about the MDEL requirements:

Recall process overview

The recall process is divided into 2 parts with 5 stages:

  1. Initiating a recall
  2. Conducting a recall

Learn more on how to properly document your establishment's recall process:

Contact us

Contact us if you have questions about medical device recalls after reading this guide.

Toll-free: 1-800-561-3350
Email: meddev-matmed@hc-sc.gc.ca

Related links

Legislation

Health Canada guidance and policy documents

ISO guidance documents

Page details

Date modified: